Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Clinical trial NCT05986864 · RECRUITING
Trial details
- NCT number
- NCT05986864
- Sponsor
- Skyline Therapeutics (US) Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-23
- Primary completion
- 2026-01-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.